Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

shutterstock_212432119

First-ever study in the personalised treatment of rare cancers brings promising results

October 18, 2017 Research and Development Cancer, Cancer Research UK, personalised medicine, pharma, rare cancer

The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …
News
mit-ai-cancer-detection-01_0

Breakthrough AI able to identify 97% of breast cancer risk

October 18, 2017 Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical

 Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …
News

Novartis sheds generics plant and 450 jobs amid pricing pressure

October 18, 2017 Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma

Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …
News
nhs_trees

New studies point to cracks forming in NHS services

October 18, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …
News

J&J’s third quarter: The good and the bad

October 18, 2017 Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …
News

Allergan’s patent shield – The (Native) American dream?

October 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

  In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …
Feature
shutterstock_159488225

AstraZeneca lung cancer drug proves able to shrink EGFR mutation-positive tumours

October 17, 2017 Manufacturing and Production, Research and Development AstraZeneca, Cancer, Chi-Med, lung cancer, pharma, savolitinib

AstraZeneca and its partner Hutchison China MedTech, also known as Chi-Med, have announced positive data for savolitinib in combination with …
News
peanuts

Peanut allergies? There’s a clinical trial looking to fix that

October 17, 2017 Manufacturing and Production, Research and Development Aimmune, Regeneron, Sanofi, biotech, drugs, peanuts, pharma, pharmaceutical

Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration …
News
shutterstock_79370437

Asking the right questions: Measuring the impact of pharmacovigilance

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …
Feature
veeva

Simplify your regulatory processes

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …
News
prevail_-_ebola_vaccination

Trials reveal two strong vaccine candidates for Ebola

October 16, 2017 Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical

Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …
News
astrazeneca_plaque

AstraZeneca admits cancer data for acquired drug was fabricated

October 16, 2017 Research and Development, Sales and Marketing Acerta, AstraZeneca, acalabrutinib

AstraZeneca has revealed that early-stage data concerning the efficacy of its acquired drug acalabrutinib in the treatment of blood cancers …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, pharmaceuticals, top ten

It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …
News
nerves

Breakthrough study could revolutionise MS treatment

October 13, 2017 Medical Communications, Research and Development biotech, drugs, multiple sclerosis, pharma, pharmaceutical

The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from …
News
news

Free Webinar: EudraVigilance changes and the impact on MAHs

October 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025